Gentian Diagnostics ASA (GENT.OL)
NOK 39.0
(0.0%)
NOK 39.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -12.76 Million NOK | 41.95% |
| 2022 | -23.23 Million NOK | -1.69% |
| 2021 | -22.84 Million NOK | -28.19% |
| 2020 | -17.82 Million NOK | 34.36% |
| 2019 | -27.15 Million NOK | -31.26% |
| 2018 | -20.68 Million NOK | -27.68% |
| 2017 | -16.2 Million NOK | -61.12% |
| 2016 | -10.05 Million NOK | -432.04% |
| 2015 | -1.89 Million NOK | -65.23% |
| 2014 | -1.14 Million NOK | -198.1% |
| 2013 | 1.16 Million NOK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.56 Million NOK | 37.4% |
| 2024 Q3 | 1.68 Million NOK | -23.74% |
| 2024 Q1 | 2.59 Million NOK | 169.3% |
| 2023 Q4 | -3.73 Million NOK | -213.41% |
| 2023 FY | -13.48 Million NOK | 41.95% |
| 2023 Q1 | -359 Thousand NOK | 91.6% |
| 2023 Q3 | -1.19 Million NOK | -201.1% |
| 2023 Q2 | 1.18 Million NOK | 428.69% |
| 2022 Q3 | -8.73 Million NOK | -663.14% |
| 2022 Q1 | -6.24 Million NOK | 34.42% |
| 2022 FY | -23.23 Million NOK | -1.69% |
| 2022 Q4 | -4.27 Million NOK | 51.11% |
| 2022 Q2 | -1.14 Million NOK | 81.67% |
| 2021 Q3 | -6.56 Million NOK | -131.47% |
| 2021 FY | -22.84 Million NOK | -28.19% |
| 2021 Q2 | -2.83 Million NOK | 27.51% |
| 2021 Q1 | -3.91 Million NOK | -28.32% |
| 2021 Q4 | -9.52 Million NOK | -44.98% |
| 2020 Q2 | -1.32 Million NOK | 79.43% |
| 2020 Q1 | -6.45 Million NOK | 14.55% |
| 2020 FY | -17.82 Million NOK | 34.36% |
| 2020 Q4 | -3.05 Million NOK | 56.36% |
| 2020 Q3 | -6.99 Million NOK | -426.43% |
| 2019 FY | -27.15 Million NOK | -31.26% |
| 2019 Q4 | -7.55 Million NOK | -30.12% |
| 2019 Q3 | -5.8 Million NOK | 10.61% |
| 2019 Q1 | -7.29 Million NOK | 13.32% |
| 2019 Q2 | -6.49 Million NOK | 11.0% |
| 2018 Q4 | -8.41 Million NOK | -1006.38% |
| 2018 FY | -20.68 Million NOK | -27.68% |
| 2018 Q1 | -4 Million NOK | 30.35% |
| 2018 Q2 | -2.46 Million NOK | 38.44% |
| 2018 Q3 | -761 Thousand NOK | 69.1% |
| 2017 Q4 | -5.74 Million NOK | -13.04% |
| 2017 Q2 | 149 Thousand NOK | 102.7% |
| 2017 Q1 | -5.52 Million NOK | -67.06% |
| 2017 FY | -16.2 Million NOK | -61.12% |
| 2017 Q3 | -5.08 Million NOK | -3510.74% |
| 2016 Q4 | -3.3 Million NOK | 31.43% |
| 2016 Q2 | -548 Thousand NOK | 51.85% |
| 2016 Q1 | -1.13 Million NOK | 6.8% |
| 2016 FY | -10.05 Million NOK | -432.04% |
| 2016 Q3 | -4.82 Million NOK | -780.29% |
| 2015 FY | -1.89 Million NOK | -65.23% |
| 2015 Q3 | -854 Thousand NOK | 0.0% |
| 2015 Q4 | -1.22 Million NOK | -42.98% |
| 2014 FY | -1.14 Million NOK | -198.1% |
| 2013 FY | 1.16 Million NOK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Lifecare AS | -35.34 Million NOK | 63.896% |
| Medistim ASA | 131.44 Million NOK | 109.709% |